Logo image of 1NOVN.MI

NOVARTIS AG-REG (1NOVN.MI) Stock Overview

Europe - BIT:1NOVN - CH0012005267 - Common Stock

111 EUR
-2 (-1.77%)
Last: 10/27/2025, 7:00:00 PM

1NOVN.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap214.88B
Revenue(TTM)54.84B
Net Income(TTM)13.65B
Shares1.94B
Float1.77B
52 Week HighN/A
52 Week LowN/A
Yearly Dividend3.27
Dividend Yield3.35%
EPS(TTM)7.51
PE14.78
Fwd PE13.69
Earnings (Next)10-28 2025-10-28/bmo
IPO2001-05-07
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


1NOVN.MI short term performance overview.The bars show the price performance of 1NOVN.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -0.5 -1 -1.5

1NOVN.MI long term performance overview.The bars show the price performance of 1NOVN.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1NOVN.MI is 111 EUR.

NOVARTIS AG-REG / 1NOVN Daily stock chart

1NOVN.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 50.76 666.31B
1LLY.MI ELI LILLY & CO 50.84 667.44B
ZEG.DE ASTRAZENECA PLC 18.95 446.01B
1JNJ.MI JOHNSON & JOHNSON 18.33 393.86B
JNJ.DE JOHNSON & JOHNSON 18.02 387.19B
RHO.DE ROCHE HOLDING AG-BR 14.16 243.26B
1ROG.MI ROCHE HOLDING AG-GENUSSCHEIN 13.94 239.54B
NOT.DE NOVARTIS AG-REG 14.84 215.73B
SNW.DE SANOFI 14.36 215.27B
1SAN.MI SANOFI 14.36 215.27B
SAN.PA SANOFI 14.19 212.63B
NOV.DE NOVO NORDISK A/S-B 13.35 198.09B

About 1NOVN.MI

Company Profile

1NOVN logo image Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Company Info

NOVARTIS AG-REG

Lichtstrasse 35

Basel BASEL-STADT CH

Employees: 75883

1NOVN Company Website

1NOVN Investor Relations

Phone: 41613241111

NOVARTIS AG-REG / 1NOVN.MI FAQ

What does NOVARTIS AG-REG do?

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.


What is the stock price of NOVARTIS AG-REG today?

The current stock price of 1NOVN.MI is 111 EUR. The price decreased by -1.77% in the last trading session.


What is the dividend status of NOVARTIS AG-REG?

NOVARTIS AG-REG (1NOVN.MI) has a dividend yield of 3.35%. The yearly dividend amount is currently 3.27.


What is the ChartMill technical and fundamental rating of 1NOVN stock?

1NOVN.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


Can you provide the PE ratio for 1NOVN stock?

The PE ratio for NOVARTIS AG-REG (1NOVN.MI) is 14.78. This is based on the reported non-GAAP earnings per share of 7.51 and the current share price of 111 EUR.


Can you provide the market cap for NOVARTIS AG-REG?

NOVARTIS AG-REG (1NOVN.MI) has a market capitalization of 214.88B EUR. This makes 1NOVN.MI a Mega Cap stock.


1NOVN.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1NOVN.MI.


Chartmill TA Rating
Chartmill Setup Rating

1NOVN.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to 1NOVN.MI. Both the health and profitability get an excellent rating, making 1NOVN.MI a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1NOVN.MI Financial Highlights

Over the last trailing twelve months 1NOVN.MI reported a non-GAAP Earnings per Share(EPS) of 7.51. The EPS increased by 22.58% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.9%
ROA 13.08%
ROE 32.52%
Debt/Equity 0.57
Chartmill High Growth Momentum
EPS Q2Q%22.84%
Sales Q2Q%9.18%
EPS 1Y (TTM)22.58%
Revenue 1Y (TTM)12.24%

1NOVN.MI Forecast & Estimates

For the next year, analysts expect an EPS growth of 16.18% and a revenue growth 9.59% for 1NOVN.MI


Analysts
Analysts68.75
Price TargetN/A
EPS Next Y16.18%
Revenue Next Year9.59%

1NOVN.MI Ownership

Ownership
Inst Owners39.6%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A